Country readiness
Which AMR entry points are ready?
Identify which priorities are supported by current capabilities, institutions, programmes and evidence.
The institutional problem
Commitments are visible. The path to implementation is harder to defend.
A country may have a national action plan. A development programme may strengthen laboratories, surveillance, health systems, agriculture or WASH. A donor may finance an intervention. An implementer may report activities. A researcher may publish a resistance signal.
But for the next appraisal, portfolio review, funding decision or evaluation, the operational questions remain difficult to answer from public evidence alone.
Which priorities are actually financed?
Which investments are genuinely attributable to AMR?
What has been implemented?
What evidence exists after delivery?
What changed - and what remains unproven?
AMR evidence is real-world work before it is a dataset.
AgentBrain keeps the operating context visible: where a record came from, what it establishes and where it cannot support a stronger conclusion.
Bring the decision, not another dataset
What are you trying to decide?
Portfolio additionality
Where would new capital add something distinct?
Map what is already financed, where investments overlap and where a real gap remains visible.
Capital to execution
Can funding be traced to delivery?
Test whether a financing commitment connects to procurement, implementation, outputs and observable results.
Programme appraisal
Which assumptions still need verification?
Show what evidence supports the proposed intervention and where the appraisal still depends on an unresolved claim.
Evaluation and learning
What changed - and what cannot yet be attributed?
Separate planned work, delivered work, observed change and unsupported outcome attribution.
AMR Signals
Follow the evidence breaks before they become portfolio risk.
Receive short notes on AMR financing, attribution and implementation traceability when a public finding changes the decision frame.
The offer
5-Day AMR Evidence Sprint
Bring one country, programme or portfolio question. Within five working days, receive a bounded, source-anchored evidence package designed for a real institutional decision.
Decision frame
Scope before evidence.
The exact question, geography, period, decision owner and review boundary.
Country or portfolio state
What exists around the decision.
Relevant priorities, capabilities, programmes, institutions and current evidence.
Capital map
Visible commitments and routes.
Projects, funders, recipients, implementation routes and financing signals.
AMR attribution
Specific, sensitive, adjacent or unresolved.
Each investment is classified without converting relevance into unsupported attribution.
Execution trace
What moved after approval.
Procurement, implementer, delivery, output and outcome evidence where available.
Unknowns
What the review could not establish.
Unresolved claims are preserved, not filled with assumptions.
Next-best evidence
The source most likely to change the answer.
A specific record, source or institutional confirmation to pursue next.
Decision briefing
20-minute findings review.
A focused review of findings, limits and available next steps.
Start with one live decision.
Small enough to review. Concrete enough to prove value. Useful even when the answer is that the evidence does not yet support the claim.
One system for understanding how the pieces relate.
AMR AgentBrain connects public evidence across policy, surveillance, financing, research and implementation into a common analytical structure.
Built for live institutional work
Not another generic AMR dashboard.
Development finance
Support country appraisal, portfolio analysis, implementation readiness and results review.
Funders and foundations
See additionality, overlap, delivery evidence and unresolved portfolio gaps.
Consultancies and evaluators
Reduce evidence reconstruction inside bids, evaluations and country assignments.
Governments and technical agencies
Connect national priorities with ownership, budgeting, implementation and monitoring evidence.
Questions answered
Which existing operations already support AMR-relevant capacity? Where are the strongest implementation entry points? Which assumptions require verification before investment or scale-up?
Reusable output
A source-anchored country or portfolio evidence pack that your team can inspect, challenge and reuse in internal review, appraisal or evaluation work.
An AMR lens for existing investments
Relevance is not attribution.
Health-system, laboratory, agriculture, WASH and One Health investments may support AMR objectives. That does not mean the entire programme or financing envelope can be attributed to AMR.
AMR-specific
AMR is an explicit objective, activity or funded component.
AMR-sensitive
The intervention strengthens a capability relevant to AMR, but the full financing is not AMR-specific.
AMR-adjacent
The programme may affect the surrounding environment, but no defensible AMR connection has yet been established.
Unresolved means the reviewed evidence is insufficient to classify the connection defensibly.
Example finding: public capital can be visible while AMR attribution remains unresolved.
From financing to results
The question is not only what was approved.
For each programme or project, the evidence chain tests what can legitimately be connected, and where the public chain stops.
01 - PriorityWhat problem or national objective was identified?
02 - CapitalWhat financing, budget or programme commitment is visible?
03 - DeliveryWho was expected to implement it, where and through which mechanism?
04 - ExecutionWhat procurement, activity or implementation evidence is available?
05 - OutputWhat was produced, installed, delivered or activated?
06 - OutcomeWhat observable change can legitimately be connected to the intervention?
Evidence that can be challenged
Every conclusion keeps its source and its limit.
SourceDocument, dataset, publication or disclosed record.
Version, locator, date and scope remain attached.
EvidenceThe specific observation extracted from the source.
What the record actually establishes.
ClassificationVerified, inferred, unknown or unresolved.
The strength of the relationship being used.
Counter-evidenceContradictions and caveats remain visible.
Claims can be downgraded when the source does not hold.
Next evidenceThe record most likely to change the conclusion.
Where review effort should go next.
Missing public evidence does not mean missing activity. AMR relevance does not equal AMR funding attribution. Traceability does not equal performance.
Evidence breaks by email
Get the next AMR Signal when a claim is downgraded, blocked or newly supported.
For readers tracking AMR capital, execution evidence and public traceability across country and portfolio work.
How Alpha supports the work
AI investigates the chain. It does not decide what becomes institutional truth.
ALPHA / AMR INTELLIGENCE RUN
question: country readiness + portfolio evidence
source_scan: plans, surveillance, finance, procurement, research
relation_test: priority -> capital -> delivery -> result
claim_status: INFERRED
financial_attribution: UNKNOWN
review_required: true
next_best_evidence: budget line or implementer confirmation
question: country readiness + portfolio evidence
source_scan: plans, surveillance, finance, procurement, research
relation_test: priority -> capital -> delivery -> result
claim_status: INFERRED
financial_attribution: UNKNOWN
review_required: true
next_best_evidence: budget line or implementer confirmation
Alpha can search sources, compare records, identify possible relationships, surface contradictions and propose evidence updates. It cannot silently promote a weak connection into a verified claim.
Automated discovery stays separate from verified claims
Canonical updates remain controlled
Publication and external action require review
Weak evidence can veto a stronger conclusion
Alpha can accelerate evidence work, but review gates determine what becomes reusable institutional knowledge.
Sample review
See how a bounded evidence brief is structured.
The sample brief shows how AMR evidence moves from source review into a decision-oriented account: what is supported, what is not supported and what would change the answer.
Open sample evidence briefRead the current governance note.
How AgentBrain delegates AI work without delegating canonical truth.
AMR Signals by email
Receive new AMR Signals when a finding changes the decision frame.
Short, source-bound notes on AMR capital, attribution gaps, implementation traceability and evidence breaks. Written for readers who need the caveat as much as the conclusion.
Bring one live decision
Which AMR question currently takes your team too long to evidence?
Bring a country question, portfolio question, funding or additionality question, implementation gap or evaluation that needs a defensible evidence base.
We will show what the reviewed evidence supports, what it does not support and what would change the answer.
Evidence to decision